Twist Bioscience Corp- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Twist Bioscience Corp 公司

Twist Bioscience Corporation 是一家合成生物學和基因組學公司，該公司開發了脫氧核糖核酸 (DNA) 合成平臺，以實現生物工程的工業化。該公司平臺的核心是一種專有技術，專門通過在硅片上寫入 DNA 來製造合成 DNA。該公司利用其技術製造各種基於合成 DNA 的產品，包括合成基因、下一代測序 (NGS) 製備工具和用於藥物發現和開發的抗體庫。其基因產品包括多路複用基因片段、表達基因、克隆基因和基因片段。該公司還生產合成核糖核酸 (RNA) 以及抗體蛋白。該公司還在 DNA 和生物藥物發現的數字數據存儲方面尋求長期機會。該公司生產的產品適用於許多行業，包括醫療保健、工業化學品、農業和學術研究。

Twist Bioscience Corp簡介



公司代碼TWST

公司名稱Twist Bioscience Corp

上市日期Oct 31, 2018

CEODr. Emily M. Leproust, Ph.D.

員工數量923

證券類型Ordinary Share

年結日Oct 31

公司地址681 Gateway Blvd.

城市SOUTH SAN FRANCISCO

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編94080

電話18007190671

網址https://www.twistbioscience.com/

公司代碼TWST

上市日期Oct 31, 2018

CEODr. Emily M. Leproust, Ph.D.

Twist Bioscience Corp公司高管



名稱

名稱/職務

職務

持股

持股變動

Dr. Emily M. Leproust, Ph.D.

Chairman of the Board, Chief Executive Officer

429.81K

-1.12%

Mr. Patrick John Finn, Ph.D.

President, Chief Operating Officer

141.81K

-1.91%

Mr. Keith L. Crandell

Independent Director

92.71K

+5.07%

Mr. Dennis Cho

Chief Legal Officer and Corporate Secretary

66.11K

-1.52%

Ms. Paula Green

Senior Vice President - Human Resources

61.66K

-1.73%

Mr. Nelson C. Chan

Independent Director

22.25K

+25.16%

Dr. Melissa A. Starovasnik, Ph.D.

Independent Director

15.81K

+39.44%

Mr. Adam Laponis

Chief Financial Officer

15.43K

+110.29%

Mr. Jan Johannessen

Independent Director

12.60K

+55.04%

Mr. Robert Werner

Chief Accounting Officer, Vice President

--

名稱

名稱/職務

職務

持股

持股變動

Dr. Emily M. Leproust, Ph.D.

Chairman of the Board, Chief Executive Officer

429.81K

-1.12%

Mr. Patrick John Finn, Ph.D.

President, Chief Operating Officer

141.81K

-1.91%

Mr. Keith L. Crandell

Independent Director

92.71K

+5.07%

Mr. Dennis Cho

Chief Legal Officer and Corporate Secretary

66.11K

-1.52%

Ms. Paula Green

Senior Vice President - Human Resources

61.66K

-1.73%

Mr. Nelson C. Chan

Independent Director

22.25K

+25.16%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

NGS tools

55.28M

57.55%

Synthetic genes

27.68M

28.82%

Antibody discovery

5.61M

5.84%

Oligo pools

5.42M

5.65%

DNA libraries

2.06M

2.14%

地區USD

名稱

營收

佔比

Americas

59.39M

61.82%

EMEA

30.74M

32.00%

APAC

5.93M

6.17%

業務

地區

業務USD

名稱

營收

佔比

NGS tools

55.28M

57.55%

Synthetic genes

27.68M

28.82%

Antibody discovery

5.61M

5.84%

Oligo pools

5.42M

5.65%

DNA libraries

2.06M

2.14%

股東統計

更新時間: 11月8日週六

持股股東

股東類型

持股股東

佔比

Artisan Partners Limited Partnership

10.62%

ARK Investment Management LLC

10.60%

The Vanguard Group, Inc.

9.53%

BlackRock Institutional Trust Company, N.A.

8.05%

William Blair Investment Management, LLC

6.47%

其他

54.72%

持股股東

佔比

Artisan Partners Limited Partnership

10.62%

ARK Investment Management LLC

10.60%

The Vanguard Group, Inc.

9.53%

BlackRock Institutional Trust Company, N.A.

8.05%

William Blair Investment Management, LLC

6.47%

其他

54.72%

股東類型

持股股東

佔比

Investment Advisor

63.08%

Investment Advisor/Hedge Fund

37.18%

Hedge Fund

12.55%

Research Firm

5.03%

Individual Investor

2.24%

Pension Fund

1.60%

Bank and Trust

0.40%

Family Office

0.17%

Insurance Company

0.07%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

566

71.88M

119.09%

+752.75K

2025Q2

575

70.44M

116.72%

-302.44K

2025Q1

585

70.23M

117.22%

-1.63M

2024Q4

578

67.47M

113.11%

-8.03M

2024Q3

588

67.80M

115.74%

-8.48M

2024Q2

579

66.59M

114.39%

-10.53M

2024Q1

565

68.18M

117.94%

-8.61M

2023Q4

559

67.81M

117.39%

-11.70M

2023Q3

560

68.09M

118.66%

-11.36M

2023Q2

577

69.42M

121.49%

-5.07M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Artisan Partners Limited Partnership

6.41M

10.62%

+1.35M

+26.67%

Sep 30, 2025

ARK Investment Management LLC

6.40M

10.6%

+158.85K

+2.54%

Jun 30, 2025

The Vanguard Group, Inc.

5.82M

9.64%

-36.15K

-0.62%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

4.86M

8.05%

+226.25K

+4.89%

Jun 30, 2025

William Blair Investment Management, LLC

3.91M

6.47%

+99.74K

+2.62%

Jun 30, 2025

State Street Investment Management (US)

2.50M

4.14%

-192.68K

-7.15%

Jun 30, 2025

EdgePoint Investment Group Inc.

2.39M

3.95%

+1.27M

+114.33%

Jun 30, 2025

Invesco Advisers, Inc.

2.29M

3.8%

-1.04M

-31.23%

Jun 30, 2025

Point72 Asset Management, L.P.

2.16M

3.58%

+725.54K

+50.64%

Jun 30, 2025

Amova Asset Management Co., Ltd.

2.30M

3.81%

-116.36K

-4.82%

Jun 30, 2025

持股ETF



更新時間: 11月6日週四

機構名稱

佔比

ARK Genomic Revolution ETF

5.08%

iShares Genomics Immunology and Healthcare ETF

3.56%

Global X Genomics & Biotechnology ETF

1.85%

ROBO Global Healthcare Technology & Innovation ETF

1.74%

ARK Innovation ETF

1.55%

WisdomTree BioRevolution Fund

1.53%

Franklin Genomic Advancements ETF

0.98%

SPDR S&P Biotech ETF

0.83%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.57%

Direxion Daily S&P Biotech Bull 3X Shares

0.43%

ARK Genomic Revolution ETF

佔比5.08%

iShares Genomics Immunology and Healthcare ETF

佔比3.56%

Global X Genomics & Biotechnology ETF

佔比1.85%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.74%

ARK Innovation ETF

佔比1.55%

WisdomTree BioRevolution Fund

佔比1.53%

Franklin Genomic Advancements ETF

佔比0.98%

SPDR S&P Biotech ETF

佔比0.83%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比0.57%

Direxion Daily S&P Biotech Bull 3X Shares

佔比0.43%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據